LCS
AMGN icon

Levin Capital Strategies’s Amgen AMGN Stock Holding History

Levin Capital Strategies’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-321,687
Closed -$52.2M – 326
2015
Q4 		$52.2M Buy
321,687
+43,556
+16% +$6.85M 0.92% 29
2015
Q3 		$38.5M Buy
+278,131
New +$43.8M 0.66% 38

Other funds holding AMGN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Levin Capital Strategies's AMGN Position: Q1 2016 in Review

Levin Capital Strategies sold out of Amgen (AMGN) in Q1 2016, closing a stake of 321,687 shares — an estimated $52.2M sold.

Levin Capital Strategies first reported a position in AMGN in Q3 2015 and held it in 2 quarters. The position peaked at $52.2M in Q4 2015. 1,434 funds tracked by Wall St. Rank hold AMGN as of Q1 2016.

  • Levin Capital Strategies reported no remaining Amgen position as of Q1 2016 after selling out during the quarter.
  • Levin Capital Strategies sold 321,687 Amgen shares in Q1 2016, an estimated $52.2M.
  • Levin Capital Strategies first reported a position in Amgen in Q3 2015 and held it in 2 quarters.
  • Levin Capital Strategies's Amgen position peaked at $52.2M in Q4 2015.
  • 1,434 funds tracked by Wall St. Rank held Amgen as of Q1 2016.

Based on Levin Capital Strategies's 13F filing for Q1 2016, filed 13 May 2016.